According to other authors, the activation of PPAR-γ relieves symptoms associated with cognitive dysfunctions and obesity, and improves the level of brain-derived neurotrophic factor (BDNF), which is reduced in depression and type 2 diabetes [9,70]. The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.